Table 2.
Resolution of anterior chamber cells and flare and pain at visit 5: integrated intent-to-treat population
| LE ointment (n = 404) | Vehicle (n = 401) | Difference (95% CI)bP valuec | |
|---|---|---|---|
| Complete resolution of anterior chamber cells and flarea | 112 (27.7%) | 50 (12.5%) | 15.3% (9.6%, 20.9%) <0.0001 |
| Grade 0 (no) paina | 305 (75.5%) | 173 (43.1%) | 32.4% (25.7%, 39.0%) <0.0001 |
Notes:
a
Patients who had missing data or took rescue medication prior to visit 5 were imputed as failures;
b
Difference in percentages; 95% CI based on asymptotic normal approximations;
c
P values from Pearson χ2 test.
Abbreviations: LE, loteprednol etabonate; CI, confidence interval.